Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Not yet recruiting	Not applicable	2026-01-28		NCT07371533

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanxi Bethune Hospital	33

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials